All stock lists
Lite Strategy, Inc. (LITS)
NASDAQ: LITS · Real-Time Price · USD
Healthcare · Biotechnology
$0.81+$0.01 (+1.56%)
Insider Score
76/ 100
LITS Insider Score
Bullish1 qualifying trade · 1 insider · $21.55K bought in the last 90 days
LITS Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Mar 31, 2025 |
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | $2.35 M | $2.91 M | $2.73 M | $3.31 M | $3.10 M | — |
| R&D Expense | $22.00 K | $36.00 K | $30.00 K | $46.00 K | $10.00 K | — |
| Operating Expenses | $2.38 M | $2.94 M | $2.77 M | $3.35 M | $3.11 M | — |
| Operating Income | -$2.38 M | -$2.94 M | -$2.77 M | -$3.35 M | -$3.11 M | — |
| Pretax Income | $16.02 M | -$13.02 M | -$23.69 M | -$30.80 M | -$3.64 M | — |
| Tax Provision | — | — | — | — | — | — |
| Net Income | $16.02 M | -$13.02 M | -$23.69 M | -$30.80 M | -$3.64 M | — |
| EPS (Basic) | $0.48 | — | -$0.66 | -$0.82 | -$0.12 | -$0.39 |
| EPS (Diluted) | $0.48 | — | -$0.66 | -$0.82 | -$0.12 | -$0.39 |
| Shares Outstanding | 33.17 M | — | 35.71 M | 37.37 M | 29.48 M | 6.66 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
